The observed absence of genetic association between ORAI1 variants and COVID-19 fatality does not eliminate the possible implication of ORAI1 in disease pathogenesis through altered gene expression levels or channel activity and therefore it does not eliminate the potential usefulness of targeting ORAI1 as a therapeutic target for COVID-19. Here, ORAI1 is linked to COVID-19.